β¨ Medicine Distribution Consents
3492 NEW ZEALAND GAZETTE, No. 133 28 AUGUST 2008
Product: Ixempra
Active Ingredient: Ixabepilone 45mg
Dosage Forms: Powder for injection
Diluent
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer: Baxter Oncology GmbH, Halle-Kunsebeck, Germany
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 22nd day of August 2008.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).
go6269
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Risperon
Active Ingredient: Risperidone 1mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: Pacific Pharmaceuticals Limited (part of Mylan)
Manufacturer: Dar Al Dawa Development & Investment Co. Limited. (DAD), Nauβr, Zabud & Sail Hisban, Nauβr, Jordan
Dated this 22nd day of August 2008.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).
go6267
Consent to the Distribution of a Changed Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the following new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Antinaus (Restricted Medicine Pack)
Active Ingredient: Prochlorperazine maleate 5mg
Dosage Form: Tablet
New Zealand Sponsor: Pacific Pharmaceuticals Limited (part of Mylan)
Manufacturer: Intas Pharmaceuticals Limited, Matoda, Gujarat, India
Product: Antinaus (Prescription Medicine Pack)
Active Ingredient: Prochlorperazine maleate 5mg
Dosage Form: Tablet
New Zealand Sponsor: Pacific Pharmaceuticals Limited (part of Mylan)
Manufacturer: Intas Pharmaceuticals Limited, Matoda, Gujarat, India
Dated this 22nd day of August 2008.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).
go6268
New Zealand Public Health and Disability Act 2000
Appointments to the Quality Improvement Committee
Pursuant to section 11 of the New Zealand Public Health and Disability Act 2000, I appoint to the Quality Improvement Committee
Dr Cynthia Farquhar
as an "ex officio" member for a three-year term of office commencing on the date of this notification.
Dated at Wellington this 5th day of August 2008.
HON DAVID CUNLIFFE, Minister of Health.
go6166
Next Page →
β¨ LLM interpretation of page content
π₯
Provisional Consent to Distribution of New Medicines
(continued from previous page)
π₯ Health & Social Welfare22 August 2008
Medicine, Provisional Consent, Ixempra, Ixabepilone, Bristol-Myers Squibb
- JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate
π₯ Consent to Distribution of New Medicine
π₯ Health & Social Welfare22 August 2008
Medicine, Consent, Risperon, Risperidone, Pacific Pharmaceuticals
- JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate
π₯ Consent to Distribution of Changed Medicine
π₯ Health & Social Welfare22 August 2008
Medicine, Consent, Antinaus, Prochlorperazine maleate, Pacific Pharmaceuticals
- JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate
π₯ Appointments to the Quality Improvement Committee
π₯ Health & Social Welfare5 August 2008
Appointment, Quality Improvement Committee, Dr Cynthia Farquhar
- Cynthia Farquhar (Dr), Appointed to Quality Improvement Committee
- HON DAVID CUNLIFFE, Minister of Health
NZ Gazette 2008, No 133